[ET Net News Agency, 4 June 2021] Wise Ally International Holdings Limited (09918) said
in April and May 2021, the group has successfully made a number of shipments of dock
devices for testers for rapid COVID-19 virus testing to a point-of-care molecular
diagnostic company based in the United States. The group provides turnkey contract
manufacturing service to the customer by manufacturing and supplying the dock devices for
the testers. The dock device, comprising printed circuit board assemblies, sensors, power
cord, electronic components and plastic parts, is a platform for single-use test cassette
to be inserted. The dock device offers heating function and provides display of the
results of the diagnostic test after biochemical reactions in the test cassette takes
place.
Based on the confirmed purchase orders received from the said molecular diagnostic
company so far, the total confirmed purchase order value in respect of the dock devices is
approximately US$7.8 million. The group anticipates a continued demand for this new
product in the foreseeable future in light of the development of the pandemic. (RC)